Out Fox The $treet

Updated - April 1, 2026 Snap was insanely cheap at $4. Not sold on selling off the Specs biz, but think an activist can push management to do more, such as hike subscription prices. Irenic appears more focused on taking $500M in savings from Specs and repurchasing cheap shares.  -Irenic, which has an economic interest of ~2.5% in Snap's Class A shares, wants the company to spin off or shutter its smart glasses business, Specs, according to a Bloomberg report on Tuesday, which cited a letter Irenic sent to Snap Chief Executive Officer and co-founder Evan Spiegel. The activist believes that moves Snap could make could boost its shares to more than $26 each. -The activist fund also wants Snap (SNAP) to rationalize its cost structure by cutting jobs and changing its compensation structure for employees, according to the report. Irenic also is pushing Snap to concentrate on adopting artificial intelligence to improve ad monetization. Irenic also recommends a stock buyback with the share...

  USA Rare Earth is aggressively ramping up production with government funding, targeting a vertically integrated rare earth supply chain. USAR's magnet and metal businesses are scaling rapidly, with sales forecast to reach $2.6 billion by 2030 and significant milestones in 2027–2029. The stock trades at less than 3x 2030 EBITDA targets, presenting a compelling long-term buy opportunity near yearly lows. The company faces execution and pricing risks, but current weakness offers attractive entry for investors willing to buy dips and sell sector-driven spikes. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » USA Rare Earth, Inc.  ( USAR ) is full-speed ahead now with government funding and plans to ramp up towards production in multiple areas. The rare earths miner and metal maker has been a solid buy  at the lows of the last year below $15. My  investment thesis ...

    Palo Alto Networks, Inc. faces valuation pressure from AI-driven competition and slowing organic growth despite platformization efforts. Recent large acquisitions—CyberArk and Chronosphere—signal gaps in PANW's platform strategy and introduce integration risks. Organic revenue growth is decelerating, with FQ3 organic guidance at only 13% and legacy business showing signs of slowdown. PANW stock still trades at 41x FY27 EPS, with a $120 valuation target, reflecting AI risks and premium multiples. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Palo Alto Networks, Inc. ( PANW ), has slumped back towards the yearly lows due to the AI threat. Even if AI doesn't replace cybersecurity, the threat will continue hitting the  valuation multiples  of the  stock. My i nvestment thesis  remains Bearish on the stock due to its expensive valuation compared to the ...

  American Airlines delivered a major Q1'26 guide-up, projecting revenue up 10% and a loss per share far better than consensus. AAL demonstrates resilience, absorbing $400M in higher fuel costs and outperforming expectations despite geopolitical and commodity headwinds. The airlines continues to drive the updated loyalty program towards $1.5B in additional pre-tax income by 2030, roughly double current levels. The stock trades at just 5x EPS targets that should reach $2, a valuation deeply discounted versus peers. In a major surprise,  American Airlines Group Inc.  ( AAL ) guided to far better than expected Q1'26 numbers. The airlines were expected to struggle this quarter due to the Iranian conflict and surging oil prices. My  investment thesis  remains ultra Bullish on the stock trading at the lows near $10 after dipping from $16. Read the full article on Seeking Alpha.  Disclosure: Long AAL. Please review the disclaimer page for more details. 

Update - Mar. 18, 2025 Tempus AI continues to slow to the lows below $50 now. The stock is tasty once the shake out is over.  Originally posted on Feb. 25 Tempus AI, Inc. has declined 50% from highs, now trading near support despite robust above $50, despite good Q4 results and strong organic growth. The AI precision medicine company delivered 33% organic growth with Diagnostics revenue expanding due to higher test ASPs. Concerns over AI replacement have pressured the stock, yet TEM's proprietary data and hospital network provide defensible moats. At 6.5x 2026 sales and strong contract retention, TEM stock appears undervalued; I am ultra Bullish and see current weakness as a buying opportunity. Tempus AI, Inc. ( TEM ) has seen the stock continue to slide over the last few months, leaving Tempus down 50% from the highs. The AI precision medicine company has seen the stock slip back to support in  the $50 to $55 range despite ongoing strong results, including a solid Q4 earnings...

Update - March 12, 2026 Rubrik reports FQ4  after the close. The current consensus is only 23% growth for FY27, so a guide up is likely. -Rubrik ( RBRK ) is scheduled to announce FQ4 earnings results on Thursday, March 12th, after market close. -The consensus EPS Estimate is -$0.11 (+38.9% Y/Y) and the consensus Revenue Estimate is $342.37M (+32.7% Y/Y) -------- FQ4 Non-GAAP EPS of $0.04  beats by $0.15 . Revenue of $377.68M (+46.3% Y/Y)   beats by $35.31M . FQ1 r evenue guidance of $365 million to $367 million vs consensus of $350.56M. FY27 revenue guidance of  $1,597 million to $1,607 million vs consensus of $1.58B. Original article posted on Feb. 12 Rubrik has declined over 50%, creating a compelling value entry for this AI-driven cybersecurity leader. RBRK's subscription ARR surged 34% in FQ3 2026 to $1.35 billion, with guidance for $1.44 billion by FY 2026 year-end. The stock trades at just 7x FY 2027 revenue and closer to 6x ARR, positioning RBRK as a top value...

Updated - March 11, 2026 Nebius has bounced back above $105 on the  NVDA  investment deal and strong earnings from Oracle. The neocloud stocks finally look ready for a breakout rally.  -Nvidia ( NVDA ) will invest $2B in Nebius ( NBIS ), and the two companies have formed a strategic partnership to develop and deploy the next generation of hyperscale cloud for the AI market. -Shares of Nebius jumped about 10% premarket on Wednesday, while Nvidia was largely flat. -The Dutch AI infrastructure provider said the partnership will help it deploy more than 5 gigawatts of Nvidia systems by the end of 2030. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Original article posted on Feb. 15 Nebius Group N.V. reported a strong ending ARR total, but the market is stuck focused on short-term revenue hiccups. NBIS is positioned as an AI cloud leader, suggesting strong long-term growt...

Updated - March 7, 2026 HIMS  closed up 40% in AHs on a surprise twist with  NVO  agreeing to a partnership.  Hims was a $30 last month and the stock trades at only 1x 2026 sales estimates of $2.7 billion.  -Novo Nordisk ( NVO ) is planning to sell its obesity drugs on the telehealth platform run by Hims & Hers Health ( HIMS ) as part of a partnership between the two firms, Bloomberg reported, citing a person familiar with the matter. -The companies are set to announce the deal as early as Monday, according to the person who sought anonymity, as the information is not yet public. -A spokesperson for the Danish drugmaker told Bloomberg, “We are always in conversation with companies that can help improve patient access to FDA-approved medicines for people living with chronic diseases. These talks happen on an ongoing basis.” HIMS was not available for comments outside regular business hours. Looking for a portfolio of ideas like this one? Members of Out Fox Th...

  Originally posted on Feb. 11 Red Cat Holdings enters Q4 earnings near highs, with anticipation building for its February 27 Innovation Day and updated long-term targets. The drone company offered preliminary Q4 revenue numbers of $24–$26.5 million, a dramatic increase from prior quarters. RCAT's valuation is compelling versus peers, trading at just 10x 2026 sales targets, with a strong $213 million cash balance and less dilution risk than Ondas. Upcoming Innovation Day could provide clarity on USV division growth and expanded order pipeline, offering potential upside to current conservative revenue targets. Red Cat Holdings, Inc. ( RCAT ) enters Q4 earnings with the stock trading back towards the highs. The company has an Innovation Day presentation each month to finally provide the market with some insights into 2026  targets and long-term goals. My  investment thesis  remains Bullish on the stock, though Red Cat isn't as cheap now as the multiple opportunities t...

  SentinelOne enters FQ4 earnings with shares trading at a yearly low due in part to AI-driven sector fears. The cybersecurity company has made a strong transition to AI-native products via internal development and recent AI-related acquisitions. The stock is cheap below 4x forward sales, while the FY27 guidance is expected to top 20% growth. SentinelOne, Inc.  ( S ) heads into FQ4 earnings with the stock oddly not trading down much over the last week due to the AI replacement fears. The cybersecurity stock was already trading substantially lower over the last 6 months due  to fears unexplained by the financial results. My  investment thesis  is ultra Bullish on SentinelOne, with signs some AI-related acquisitions are paying off. Read the full article on Seeking Alpha.  Disclosure: Long S. Please review the disclaimer page for more details. 

  Hims & Hers Health, Inc. remains ultra Bullish despite a near 80% drawdown from 52-week highs, with growth initiatives firmly on track. HIMS projects 2026 revenues of $2.7–$2.9 billion, above consensus, and expects strong subscriber growth in weight loss offerings despite temporary GLP-1 headwinds. The Eucalyptus acquisition is set to add at least $200 million to 2026 revenues, positioning HIMS for a $3.25–$4 billion annualized run rate entering 2027. Regulatory risks from DoJ, FDA, and SEC persist, but HIMS emphasizes GLP-1s are only one part of its diversified health platform, making the stock cheap at only 1x sales. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Hims & Hers Health, Inc. ( HIMS ) has seen the stock make a huge reversal after an initial post-Q4 selloff. The online health and wellness platform is full-speed ahead on growth initiatives while the stock ...

  Cipher Mining, rebranding as Cipher Digital, is pivoting from bitcoin mining to AI data center leasing, with major contracts secured. CIFR has $9.3 billion in long-term leases with AWS and Google, covering only a fraction of its 4+ GW power capacity, highlighting substantial future monetization potential. Despite near-term revenue gaps and execution risk, CIFR trades at 10x NOI from existing leases, with significant upside as additional contracts are secured. Future lease announcements and successful hyperscaler data center operations are key catalysts, while risks include execution uncertainty and potential shifts in data center demand. Cipher Mining Inc.  ( CIFR ) recently entered the AI data center race, so quarterly results were expected to be volatile until the business scales. The company has signed substantial leases for data centers, but investors have to be patient with leases not  starting until end of this year. My  investment thesis  is more Bullis...

Update - Feb. 20, 2026 CoreWeave is slumping due to a misleading report from BI. The AI cloud company has not run into problems financing a data center in PA despite the reporting. The company has already completed the data center financing as reported in the BI article and confirmed on air by Jim Cramer after exchanging messages with the CEO.  Update - Jan. 26, 2026 NVDA  wisely buying into  CRWV  at less than 4x '26 sales and close to 2x '27 sales. The market doubting this AI data center story was crazy. -Nvidia (NVDA) has invested $2B in CoreWeave (CRWV) and expanded their collaboration to help CoreWeave accelerate the buildout of over 5 gigawatts of AI factories by 2030. -Nvidia invested $2B in CoreWeave Class A common stock at $87.20 per share. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Original article posted on Nov. 17  CoreWeave remains an ultra ...

Hims & Hers Health trades at yearly lows amid market hysteria over compounded oral Wegovy and regulatory scrutiny. The online health platform is not a GLP-1-centric company; weight-loss sales are forecast at only 30% of 2025 revenue, with a broader focus on preventative care and platform growth. Recent FDA and Novo Nordisk actions should have limited impact, as HIMS already pulled the oral Wegovy, and the market has overreacted to worst-case scenarios. The stock is cheap, trading with a current valuation of just 1.5x 2026 revenue, while platform expansion and new treatments suggest conservative analyst forecasts. Hims & Hers Health, Inc.  ( HIMS ) slumped to yearly lows as the market fed into investor hysteria over a compounded version of the Wegovy pill. The health and wellness platform isn’t focused on GLP-1s, as the goal is proactive preventative  care, but the market is reacting to the FDA aggressively working towards the company not offering compounded GLP-1s. My...

Update - Feb. 4, 2026 Super Micro reported an impressive Q4'25 as forecast.  -Q2 Non-GAAP EPS of $0.69 beats by $0.20. -Revenue of $12.7B (+122.8% Y/Y) beats by $2.36B. -The Company expects net sales of at least $12.3 billion vs $10.20B consensus for the third quarter of fiscal year 2026 ending March 31, 2026, GAAP net income per diluted share of at least $0.52 and non-GAAP net income per diluted share of at least $0.60 vs $0.52 consensus. -For fiscal year 2026, the Company expects net sales of at least $40.0 billion. The Out Fox Investing Group was alerted to Buy SMCI at $29.60 prior to earnings. The stock is up to $33.50 now, but the Bull Case is for a $7+ EPS in FY27.  Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Original article posted on Jan. 18 Super Micro Computer has pulled back to yearly lows due to recent accounting concerns and order upshots despite strong AI ...